BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16870044)

  • 21. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
    Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
    Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
    Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
    Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
    Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI
    Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
    Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
    Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
    Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
    Park HJ; Yu E; Shim YH
    Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.
    Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K
    Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.
    Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY
    Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT
    Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.